A detailed history of Simplex Trading, LLC transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 214 shares of MIST stock, worth $398. This represents 0.0% of its overall portfolio holdings.

Number of Shares
214
Previous 1,191 82.03%
Holding current value
$398
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$1.29 - $1.65 $1,260 - $1,612
-977 Reduced 82.03%
214 $0
Q2 2024

Jul 25, 2024

BUY
$1.29 - $1.83 $919 - $1,304
713 Added 149.16%
1,191 $1,000
Q1 2024

Apr 25, 2024

SELL
$1.4 - $2.2 $851 - $1,337
-608 Reduced 55.99%
478 $0
Q4 2023

Feb 02, 2024

BUY
$1.67 - $3.39 $1,813 - $3,681
1,086 New
1,086 $1,000
Q2 2023

Aug 04, 2023

BUY
$2.85 - $4.4 $10,225 - $15,787
3,588 New
3,588 $10,000
Q4 2020

Feb 02, 2021

SELL
$5.57 - $7.66 $328 - $451
-59 Closed
0 $0
Q3 2020

Oct 14, 2020

BUY
$3.34 - $9.8 $197 - $578
59 New
59 $0

Others Institutions Holding MIST

About Milestone Pharmaceuticals Inc.


  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $55.8M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.